Can popular weight loss drugs lower cancer risk? Medscape (subscription required): David Kaelber, associate professor at the School of Medicine, called GLP-1 agonists “almost like wonder drugs” due to their potential benefits beyond managing diabetes and weight loss, including cancer risk reduction. However, he cautioned that existing evidence is based on observational studies, and the findings should be interpreted cautiously until further research confirms any cancer prevention effects.
